Qiagen (QGEN) said Friday that it has expanded the capacity of its QIAcuity Digital PCR system to simultaneously detect up to 12 targets from one biological sample, from its previous capability of up to five targets.
The upgraded capability was made possible by a software update and the company's newly launched QIAcuity High Multiplex Probe PCR kits, without the need for any hardware changes, the company said.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.